Navigation Links
Cornerstone Pharmaceuticals Announces Positive Results of Emulsiphan Safety Study
Date:3/14/2011

CRANBURY, N.J., March 14, 2011 /PRNewswire/ -- Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.

"We are so pleased that Cornerstone has received a report from NCI indicating that Emulsiphan appears to be safe and capable as a drug delivery solution for anticancer agents," said Dr. Robert Shorr, CEO of Cornerstone Pharmaceuticals, Inc.

"Combining anticancer agents with a targeted drug delivery technology, such as Emulsiphan, could greatly improve patient outcomes. We look forward to the next phase of preclinical study in our ongoing collaboration with NCI."

The preclinical study, which looked at the safety of azide drug-loaded Emulsiphan nano emulsions, is the first step in a collaboration between Cornerstone and NCI to apply Cornerstone's drug delivery platform to a class of novel chemotherapy agents developed by Dr. Yossef Raviv in the laboratory of the renowned biologist Dr. Robert Blumenthal at NCI's Center for Cancer Research Nanobiology Program.

Selective drug delivery remains a formidable challenge in the successful treatment of cancer. Often, just a small percentage of the active ingredients in chemotherapies administered to treat tumors ever reach the desired target within cancer cells and considerable amounts of drug spread to healthy cells and tissue.

Emulsiphan is a novel, cancer selective drug-delivery nanotechnology that aims to deposit cancer-fighting drugs directly into cancer cells--not just the tumor mass--by focusing on the distinct metabolism of these cells.  The nanotechnology is designed to maximize drug concentration into tumor cells, thereby enhancing the anti-cancer compoun
'/>"/>

SOURCE Cornerstone Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call
2. Cornerstone Therapeutics to Host Third Quarter 2010 Conference Call
3. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
4. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
5. Cornerstone Therapeutics Announces Collaboration with The Cough Company
6. Cornerstone Therapeutics to Host Second Quarter 2010 Conference Call
7. Cornerstone Therapeutics Announces Management Change
8. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
9. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
10. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
11. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015   InspireMD, Inc.  ("InspireMD" or the ... systems ("EPS"), today announced that it has entered into ... million shares of common stock and warrants to purchase ... in a public offering.  The common stock will be ... share, and each purchaser will receive a warrant to ...
(Date:3/4/2015)... Israël, 4 mars 2015 /PRNewswire/ ... (« RedHill » ou la « Société »), une ... sur les spécialités pharmaceutiques administrés ... stade clinique avancé pour les ... notamment les cancers gastro-intestinaux, a ...
(Date:3/4/2015)... -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced today ... at the Ritz-Carlton at Laguna Niguel, California ... Arthur S. Przybyl , President and CEO, will give the ... ANI,s website at www.anipharmaceuticals.com . Mr. Przybyl,s presentation will ... available through the link through June 7, 2015. ...
Breaking Medicine Technology:InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 2RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 3RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 5ANI Pharmaceuticals To Present At 27th Annual ROTH Conference 2
... YORK, Jan. 12, 2011 NeoStem, Inc. (NYSE Amex: ... company with operations in the U.S. and China, today announced ... present on Wednesday, January 12, 2011 at the OneMedForum 2011 ... at 11:00 AM PST. Both events will be held in ...
... InstaCare Corp. (OTC Bulletin Board:  ISCR) a ... testing products for the chronically ill, a leading ... and a leading developer of revolutionary cell phone ... company,s Board of Directors has received the initial ...
Cached Medicine Technology:NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 2NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011 3InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA 2
(Date:3/4/2015)... The defibrillators report provides insights into the growth ... the global market is expected to grow at a ... by 2019. It expects the emerging markets to provide ... established players in the market. , According to the ... at the highest CAGR during the next five years. ...
(Date:3/4/2015)... San Jose, California (PRWEB) March 04, 2015 ... rapidly becoming a worrisome public health issue worldwide. The ... a major economic and social burden in both developed ... cases globally is projected to rise to 1.5 billion, ... About 75% of these patients are forecast to come ...
(Date:3/4/2015)... Developers of FCPX plugins and theme templates ... Final Cut Pro X entitled FCPX Overlays Lens Dirt from ... total control over 6k lens dirt overlays inside Final Cut ... “FCPX Overlays Lens Dirt was professionally designed to add level ... FCPX Overlays Lens Dirt from Pixel Film Studios brings FCPX ...
(Date:3/4/2015)... March 04, 2015 The medical device ... whose management forgot – or ignored or didn't know ... the market based on physician input before proceeding to ... more specifically, founders – become so enamored of an ... question: Will physicians use the device?” says Dr. ...
(Date:3/3/2015)... On February 24, 2015, a Toledo, Ohio homeowner ... Court for the Northern District of Ohio against mortgage ... companies Balboa, QBE, and Newport Management. (See Amended Complaint ... The Plaintiff, a Ms. Dolores Gorsuch, says her mortgage ... buy too much insurance at rates that were too ...
Breaking Medicine News(10 mins):Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 2Health News:Defibrillators Market worth $12.9 Billion by 2019 with Rise in Aging Population - New Research Report by MarketsandMarkets 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Pixel Film Studios released a New Overlay Plugin entitled FCPX Overlays Lens Dirt Exclusively for Final Cut Pro X users 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3Health News:Borrower Accuses Mortgage Lenders of Racketeering in Forcing Insurance on Homeowners 2
... or purchase. , ... New York, ... a global leader in electronic content delivery solutions, today announced ... e-book portal using iPublishCentral ( www.ipublishcentral.com ), an easy-to-implement, cost-effective, ...
... Online health publisher, Healthcommunities.com, Inc., announces recent additions to urologychannel.com, ... in the extensive STD information section, will help ... plans and prevent STD complications. , ... ...
... Under counter ionizer converts to counter top for travel use. , ... Carlsbad, CA (PRWEB) ... mineral water at home or in the office has become a lot ... Ionizers., , , , ,The company today announced the availability of its enhanced ...
... of Spinal Muscular Atrophy has just launched a new Medical ... one of the most highly respected bodies of SMA medical ... proactive, creative, and collaborative leadership on issues that improve the ... new Council will focus on educating families, health care providers, ...
... Attorney General Eric Holder and Health and Human Services Secretary Kathleen ... protect taxpayer dollars on WEDNESDAY, MAY 20, ... Attorney General Eric Holder , Secretary Kathleen Sebelius WHAT: ... 20, 2009 , 1:00 P.M. ET WHERE: ...
... Democrats advance patient-centered CERWASHINGTON, May 19 ... Members of the New Democrat Coalition, Tony Coelho, ... (PIPC), spoke with reporters and announced PIPC,s support ... bill represents an important step forward for patients ...
Cached Medicine News:Health News:American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy 2Health News:American College of Physicians Chooses iPublishCentral to Launch its e-Book Strategy 3Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 2Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 3Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 2Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 3Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 3Health News:PIPC Supports New Comparative Effectiveness Research (CER) Bill 2
... The Vision5L Digital ... 5- or 7-lead, ... a signal preview,screen. ... using a compact,flash ...
The Atria 6100 delivers the highest level of clinical performance while incorporating cutting-edge technology to streamline clinic workflow. It offers timely, high-quality, and accurate ECG results c...
... CSV-1000CVA test face is used to evaluate both ... levels (high, 25% and 12.5%) of LogMAR acuity ... face as well as the two spatial frequencies ... most widely used for cataract documentation because eye ...
... is used widely for screening refractive surgery ... from 20/10 to 20/100 and one row ... ,The patient can be easily screened in ... contrast sensitivity. If a contrast sensitivity deficit ...
Medicine Products: